Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (34)
Yao‐Yu Hsieh, Jia‐Ling Du & Pei‐Ming Yang. (2023)
Repositioning
VU
‐0365114 as a novel microtubule‐destabilizing agent for treating cancer and overcoming drug resistance
. Molecular Oncology.
Crossref
Crossref
Lin Zhang, Qiwei Pan, Yi Wu, Peng Zhang, Shibao Li, Yuting Xu, Danhua Li, Maojin Zheng, Dongsheng Pei & Qingling Wang. (2023) ORP8 inhibits renal cell carcinoma progression by accelerating Stathmin1 degradation and microtubule polymerization. Experimental Cell Research 427:1, pages 113601.
Crossref
Crossref
Mana Azumi, Mikihiro Yoshie, Wataru Takano, Akari Ishida, Kazuya Kusama & Kazuhiro Tamura. (2022) The Impact of Eribulin on Stathmin Dynamics and Paclitaxel Sensitivity in Ovarian Cancer Cells. Biological and Pharmaceutical Bulletin 45:11, pages 1627-1635.
Crossref
Crossref
Shahrukh R. Ali, Madeleine Jordan, Priyadharsini Nagarajan & Moran Amit. (2022) Nerve Density and Neuronal Biomarkers in Cancer. Cancers 14:19, pages 4817.
Crossref
Crossref
Sander Bekeschus, Grit Liebelt, Jonas Menz, Debora Singer, Kristian Wende & Anke Schmidt. (2022) Cell cycle-related genes associate with sensitivity to hydrogen peroxide-induced toxicity. Redox Biology 50, pages 102234.
Crossref
Crossref
Ahmed A. H. Abdellatif, Asmaa T. Ali, Abdellatif Bouazzaoui, Mansour Alsharidah, Osamah Al Rugaie & Nahla Sameh Tolba. (2022) Formulation of polymeric nanoparticles loaded sorafenib; evaluation of cytotoxicity, molecular evaluation, and gene expression studies in lung and breast cancer cell lines. Nanotechnology Reviews 11:1, pages 987-1004.
Crossref
Crossref
Premila D. Leiphrakpam, Audrey J. Lazenby, Lynette M. Smith, Michael G. Brattain & Chandrakanth Are. (2021) Stathmin expression in metastatic colorectal cancer. Journal of Surgical Oncology 123:8, pages 1764-1772.
Crossref
Crossref
Szu-Jen Wang & Pei-Ming Yang. (2021) A Bioinformatics Analysis Identifies the Telomerase Inhibitor MST-312 for Treating High-STMN1-Expressing Hepatocellular Carcinoma. Journal of Personalized Medicine 11:5, pages 332.
Crossref
Crossref
Ning Yang, Hongzhi Wang, Weicheng Zhang, Houyi Sun, Meng Li, Yaozeng Xu, Lixin Huang & Dechun Geng. (2021) Integrated analysis of transcriptome and proteome to explore the genes related to steroid-induced femoral head necrosis. Experimental Cell Research 401:1, pages 112513.
Crossref
Crossref
Du Shi, Zhe Zhang & Chuize Kong. (2021) CARMA3 Transcriptional Regulation of STMN1 by NF-κB Promotes Renal Cell Carcinoma Proliferation and Invasion. Technology in Cancer Research & Treatment 20, pages 153303382110279.
Crossref
Crossref
Xian-Mei Wen, Tao Luo, Yi Jiang, Li-Hong Wang, Ying Luo, Qian Chen, Kaidi Yang, Ye Yuan, Chunhua Luo, Xiang Zhang, Ze-Xuan Yan, Wen-Juan Fu, Yu-Huan Tan, Qin Niu, Jing-Fang Xiao, Lu Chen, Jiao Wang, Jia-Feng Huang, You-Hong Cui, Xia Zhang, Yan Wang & Xiu-Wu Bian. (2020) Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme. Laboratory Investigation 100:6, pages 812-823.
Crossref
Crossref
Jianping Xu, Wei Wu, Yao Tang, Yanfeng Lin, Yan Xue, Jianda Hu & Donghong Lin. (2019) PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling. Aging 11:18, pages 7817-7829.
Crossref
Crossref
Pavel Dundr, Karol Simon, Kristýna Němejcová, Michaela Bártů, Ivana Tichá, Romana Michálková, Radek Jakša, Zuzana Věcková & Ondřej Kodet. (2019) Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions. Melanoma Research 29:2, pages 157-162.
Crossref
Crossref
Lei Zhao, Dejun Zhang, Qiong Shen, Min Jin, Zhenyu Lin, Hong Ma, Shaoyi Huang, Pengfei Zhou, Gang Wu & Tao Zhang. (2018) KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway. Oncogene 38:7, pages 935-949.
Crossref
Crossref
Ping Liu, Junyan Yu, Xiangyang Tian, Jianlan Chang, Ying Zhang, Rong Zhang, Ningning Zhang, Ranxing Huang, Lulu Li, Xianli Qiao & Hongliang Guo. (2018) The effect of downregulation of Stathmin gene on biological behaviors of U373 and U87-MG glioblastoma cells. Biological Research 51:1.
Crossref
Crossref
Hao Wu, Wei-Wei Deng, Lei-Lei Yang, Wen-Feng Zhang & Zhi-Jun Sun. (2018) Expression and phosphorylation of Stathmin 1 indicate poor survival in head and neck squamous cell carcinoma and associate with immune suppression. Biomarkers in Medicine 12:7, pages 759-769.
Crossref
Crossref
Yan Zhou, Gaoxiang Yang, Hua Tian, Yabin Hu, Sai Wu, Yang Geng, Kai Lin & Wei Wu. (2018) Sulforaphane metabolites cause apoptosis via microtubule disruption in cancer. Endocrine-Related Cancer 25:3, pages 255-268.
Crossref
Crossref
Xiaobo Bo, Jie Wang, Qiang Fu, Yueqi Wang, Houbao Liu & Jiejie Xu. (2017) Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma. Oncotarget 8:65, pages 108548-108555.
Crossref
Crossref
Lin Yurong, Rong Biaoxue, Li Wei, Ming Zongjuan, Shi Hongyang, Fang Ping, Gao Wenlong, Yang Shuanying & Li Zongfang. (2016) Stathmin overexpression is associated with growth, invasion and metastasis of lung adenocarcinoma. Oncotarget 8:16, pages 26000-26012.
Crossref
Crossref
Fang Shen, Dan Long, Ting Yu, Xian Chen, Ying Liao, Yi Wu & Xuechi Lin. (2017) Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin. Oncology Reports.
Crossref
Crossref
Yan Chen, Qicheng Zhang, Chuanjin Ding, Xiaobo Zhang, Xiaoxia Qiu & Zhenxin Zhang. (2017) Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration. International Journal of Oncology 50:1, pages 31-40.
Crossref
Crossref
Rong Biaoxue, Liu Hua, Gao Wenlong & Yang Shuanying. (2016) Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis. Oncotarget 7:48, pages 78994-79007.
Crossref
Crossref
Linan Wang, Owen E. Branson, Konstantin Shilo, Charles L. Hitchcock & Michael A. Freitas. (2016) Proteomic Signatures of Thymomas. PLOS ONE 11:11, pages e0166494.
Crossref
Crossref
Hai-Long Ma, Shu-Fang Jin, Wen-Jie Tao, Mao-Lin Zhang & Zhi-Yuan Zhang. (2016) Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma. Journal of Cranio-Maxillofacial Surgery 44:10, pages 1725-1732.
Crossref
Crossref
Wei Lu, Yunping Hu, Qiang Ma, Linzhu Zhou, Lin Jiang, Zhizhen Li, Shuai Zhao, Yuzhen Xu, Weibin Shi, Sheng Li & Yingbin Liu. (2016) miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. Oncotarget 7:38, pages 62364-62376.
Crossref
Crossref
Lu Guo, Caixia Zhang, Jinghong Zhu, Yuqin Yang, Jianfa Lan, Gang Su & Xiaodong Xie. (2016) Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer. Life Sciences 151, pages 102-108.
Crossref
Crossref
Jun Liu, Jian Cao & Xiaokun Zhao. (2015) miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1. BMC Urology 15:1.
Crossref
Crossref
Nithya SubramanianJagat R. KanwarRupinder K. KanwarSubramanian Krishnakumar. (2015) Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras. Nucleic Acid Therapeutics 25:6, pages 317-322.
Crossref
Crossref
Laura M. Knight, Gabriele Stakaityte, Jennifer, J. Wood, Hussein Abdul-Sada, David A. Griffiths, Gareth J. Howell, Rachel Wheat, G. Eric Blair, Neil M. Steven, Andrew Macdonald, David J. Blackbourn & Adrian Whitehouse. (2015) Merkel Cell Polyomavirus Small T Antigen Mediates Microtubule Destabilization To Promote Cell Motility and Migration. Journal of Virology 89:1, pages 35-47.
Crossref
Crossref
Yu Lu, Chen Liu, Yong-Feng Xu, He Cheng, Si Shi, Chun-Tao Wu & Xian-Jun Yu. (2014) Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transition. Hepatobiliary & Pancreatic Diseases International 13:4, pages 386-394.
Crossref
Crossref
Sebahat Ocak, David B. Friedman, Heidi Chen, Jamie A. Ausborn, Mohamed Hassanein, Bruno Detry, Birgit Weynand, Frank Aboubakar, Charles Pilette, Yves Sibille & Pierre P. Massion. (2014) Discovery of New Membrane-Associated Proteins Overexpressed in Small-Cell Lung Cancer. Journal of Thoracic Oncology 9:3, pages 324-336.
Crossref
Crossref
SHU GONG, ZHONGHUA TAO, XIAOYAN LIU & LIN GAN. (2014) An underlying prognosis predictor of hepatocellular carcinoma: Oncoprotein 18. Biomedical Reports 2:1, pages 85-88.
Crossref
Crossref
Kazuhiro Tamura, Mikihiro Yoshie, Eri Miyajima, Mika Kano & Eiichi Tachikawa. (2013)
Stathmin Regulates Hypoxia-Inducible Factor-1
Expression through the Mammalian Target of Rapamycin Pathway in Ovarian Clear Cell Adenocarcinoma
. ISRN Pharmacology 2013, pages 1-8.
Crossref
Crossref
Zheng Wei, Xian Jiang, Haiquan Qiao, Bo Zhai, Lianfeng Zhang, Qiang Zhang, Yuanhong Wu, Hongchi Jiang & Xueying Sun. (2013) STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells. Cellular Signalling 25:4, pages 931-938.
Crossref
Crossref